ArticleBosnian journal of basic medical sciences2021

Combined inhibition of ACK1 and AKT shows potential toward targeted therapy against KRAS-mutant non-small-cell lung cancer.

Xiangjing Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.